Bengal Pink Radioactive

Radioactive rose bengal, or rose bengal I131, is one of the most common radioisotopes of iodine, which is used in medicine to diagnose and treat various diseases.

Radioactive rose bengal was discovered in 1932 by the University of Bengal in India. It has an atomic number of 53 and a mass number of 131. This radioisotope emits beta particles with an energy of about 0.3 MeV and a half-life of about 8 days.

In medicine, rose bengal radioisotope is used to diagnose thyroid diseases such as thyroid cancer and goiter. It is also used to treat thyroid cancer.

For this purpose, a special preparation is used that contains radioactive iodine. The drug is introduced into the patient's body through injection or inhalation. The radioactive iodine then accumulates in the thyroid gland, where it emits beta radiation. This radiation can be detected using special equipment - a gamma camera, which allows you to visualize the distribution of radioactive iodine in the body.

Based on the results of the examination, the doctor can determine the presence and extent of thyroid disease, as well as choose the optimal treatment method.

One of the advantages of using radioactive rose bengal is that it does not cause allergic reactions, unlike other radioisotopes that can be used to diagnose diseases. This allows it to be used even in patients allergic to iodine.

However, like any other radioisotope, radioactive rose bengal may cause some side effects such as nausea, vomiting and headache. In addition, long-term exposure to radiation can damage the body's cells. Therefore, it is necessary to observe safety precautions when working with radioactive isotopes.

Thus, radioactive rose bengal remains an important tool in the diagnosis and treatment of thyroid diseases.

Bengal pink radioactive gamma-emitting radiopharmaceutical dosage form, solution for intravenous administration. The permissible dose interval is from 0.1 to 5 mSv/year. Potential use is in nuclear medicine to perform thyroid studies (function studies) in patients presenting for treatment.